Overview

Treatment of Demodex Blepharitis With Ivermectin Gel 0.1% Plus Metronidazole 1%

Status:
Completed
Trial end date:
2015-01-01
Target enrollment:
Participant gender:
Summary
Blepharitis is a endemic inflammatory disease caused mainly by Demodex folliculorum and Demodex Brevis, This mites are often associated with anaerobic bacteria that produces a skin inflammation, so a intervention that reduces the number of mites and bacteria would be desirable. Ivermectin a macrolid compound have demonstrated activity against scabies and lice in humans and in animals and a single application have show a good response in lice eradication. In this study , investigators will determinate the security and effectiveness of this compound in the eradication of mites
Phase:
Phase 3
Details
Lead Sponsor:
Universidad Nacional de Colombia
Treatments:
Ivermectin
Metronidazole